-
EP3938494
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3938494
| EP3938494 - IMMUNOMODULATING MESENCHYMAL STEM CELLS [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 04.11.2022 Database last updated on 24.01.2025 | |
| Former | Request for examination was made Status updated on 17.12.2021 | ||
| Former | The international publication has been made Status updated on 19.09.2020 | ||
| Former | unknown Status updated on 16.03.2020 | Most recent event Tooltip | 23.01.2025 | New entry: Despatch of examination report + time limit | Applicant(s) | For all designated states Boehringer Ingelheim Veterinary Medicine Belgium Noorwegenstraat 4 9940 Evergem / BE | [2022/03] | Inventor(s) | 01 /
SPAAS, Jan Heffink 8 9940 Evergem / BE | 02 /
BROECKX, Sarah Heffink 8 9940 Evergem / BE | [N/P] |
| Former [2022/03] | 01 /
SPAAS, Jan 9940 Evergem / BE | ||
| 02 /
BROECKX, Sarah 9940 Evergem / BE | Representative(s) | Brantsandpatents bv Pauline Van Pottelsberghelaan 24 9051 Ghent / BE | [N/P] |
| Former [2022/03] | Brantsandpatents bvba Pauline Van Pottelsberghelaan 24 9051 Ghent / BE | Application number, filing date | 20708513.5 | 12.03.2020 | [2022/03] | WO2020EP56625 | Priority number, date | EP20190162270 | 12.03.2019 Original published format: EP 19162270 | [2022/03] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020182935 | Date: | 17.09.2020 | Language: | EN | [2020/38] | Type: | A1 Application with search report | No.: | EP3938494 | Date: | 19.01.2022 | Language: | EN | The application published by WIPO in one of the EPO official languages on 17.09.2020 takes the place of the publication of the European patent application. | [2022/03] | Search report(s) | International search report - published on: | EP | 17.09.2020 | Classification | IPC: | C12N5/0775 | [2022/03] | CPC: |
C12N5/0668 (EP,KR,US);
A61K35/28 (KR,US);
A61P37/02 (KR);
C12N2501/02 (EP);
C12N2501/03 (EP);
C12N2501/15 (EP);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/03] | Title | German: | IMMUNMODULIERENDE MESENCHYMALE STAMMZELLEN | [2022/03] | English: | IMMUNOMODULATING MESENCHYMAL STEM CELLS | [2022/03] | French: | CELLULES SOUCHES MÉSENCHYMATEUSES IMMUNOMODULATRICES | [2022/03] | Entry into regional phase | 11.10.2021 | National basic fee paid | 11.10.2021 | Designation fee(s) paid | 11.10.2021 | Examination fee paid | Examination procedure | 01.12.2020 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 11.10.2021 | Examination requested [2022/03] | 11.10.2021 | Date on which the examining division has become responsible | 03.11.2022 | Despatch of a communication from the examining division (Time limit: M04) | 16.01.2023 | Reply to a communication from the examining division | 22.01.2025 | Despatch of a communication from the examining division (Time limit: M04) | Fees paid | Renewal fee | 11.10.2021 | Renewal fee patent year 03 | 23.03.2023 | Renewal fee patent year 04 | 27.03.2024 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | WO2005093044 [ ] (OSIRIS THERAPEUTICS INC [US], et al); | [X]US2008095749 (AGGARWAL SUDEEPTA [US], et al); | by applicant | EP1066052 | US2011311496 | US2014017787 | EP3429360 |